Testosterone Terminated Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00515112Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer